Borupblevins1767

50 years. The topical treatment statistically significantly (p = 0.0001) alleviated the symptoms of xerostomia and improved their quality of life (OHIP-14 scores) (p = 0.0001). We observed a statistically significantly IDWG (kg) and IDWG% reduction (p = 0.03) after the use of topical treatment for xerostomia. None of the patients reported side effects. Conclusions Xerostomia might affect the quality of life and increase the IDWG of these patients. The daily use of topical treatment for xerostomia could decrease thirst and IDWG, improving the quality of life of HD patients. Future randomised studies are needed to confirm these results.Purpose Some authors have highlighted the danger of intraoral use of rotating instruments which can produce droplets and aerosols. During the Covid lockdown phase, dental operators were limited to providing emergency treatment that could not be postponed. click here Therefore, it is necessary for the dental team to restart safely to treat neglected oral diseases that may also affect systemic health. The role of the dental hygienist has apparently changed for procedures performed close to the patient's oral cavity, particularly in terms of the droplets and aerosols produced during oral hygiene practices. Through an analysis of the most recent literature on the use of dedicated PPE and changed post-Covid 19 work processes, and a review of the differences between manual causal therapy and mechanical therapy in terms of outcome after oral hygiene treatment, we define how the role of the dental hygienist can change positively. Materials and Methods Narrative reviews of the literature in terms of PPE adopted and oral hygiene procedures performed were carried out in Pubmed. Results 188 articles from February 2020 to May 2020 using the search terms 'dentistry' and 'covid-19' were examined. 10 reviews of the literature were performed using the search terms 'mechanical procedures' and 'manual hygiene'. Conclusion Only continuous update of evidence-based literature on the new standards in oral hygiene procedures and the different results yielded by different procedures can ensure a safe working environment for the dental hygienist while supporting the dentist in this phase of the pandemic.Purpose Evidence has shown that silver diamine fluoride (SDF) at 30-38% has the potential to control and revert caries lesions. However, SDF can be found at lower concentrations on the market. In this study, we evaluated the effect of different commercially available SDF products on the progression of non-cavitated caries lesion in primary teeth assessed by a pH-cycling model. Materials and Methods Subsuperficial caries lesions were formed in primary teeth using a demineralising solution for 96 h. Demineralised samples were randomly allocated to the following groups (n = 12/group) (G1) Negative Control, deionised water; (G2) Cariostatic, Inodon; 10%* SDF; (G3) Cariestop, Biodynamics, 12%* SDF; (G4) Cariostal, Iodontec, 16%* SDF; (G5) Cariestop, Biodynamics, 30%* SDF (*concentrations declared in the label). Products were applied according to the manufacturer's recommendation and reapplied after 7 days. Samples were exposed to a pH-cycling model for 14 days. After the cycle was completed, samples were sectioned, analysed by polarised light microscopy, and lesion depth was estimated as indicator of caries lesion progression. Groups were compared by multiple comparisons test (p < 0.05). Results The negative control group exhibited the greatest lesion depth. All SDF products reduced the caries lesions depth and differed from the negative control. It was a trend observed (G1>G2>G3>G4), but no statistical differences among G3, and G5, and between G4 and G5 were observed for lesion depth. Conclusion The tested SDF products reduced the depth of non-cavitated carious lesions in primary enamel. Although SDF products with declared concentrations between 12% and 30% (G3, G4, and G5) demonstrated a similar lesion depth in primary enamel, the effect of the concentration remains unclear.Oral/dental healthcare delivery in the post-pandemic era will be different, with challenges to overcome and positive opportunities to take. Managing the needs, wants and expectations of all stakeholders must be communicated and actioned effectively, moving forwards. It is the responsibility of all stakeholders to work together to help provide high quality, evidence-based pragmatic oral healthcare delivery for the future. Patient-focused, team-delivered, minimum intervention oral healthcare (MIOC) is applicable to all patients at all stages of their lives and underpins long-term delivery of better oral and systemic health to all. Guidance, peer-support, whole-team training along with agile commissioning and suitable incentivisation will need to support the paradigm shift to prevention-based MIOC clinical practice.

Exposures to environmental toxins have been associated with severe health problems for approximately one-quarter of the nearly 700,000 U.S. soldiers who served in the Gulf War between the years 1990 and 1991. Gulf War illness still affects about 30% of Gulf War veterans (GWV), causing reduced psychological wellness and neuropsychological function.

This pilot study used a randomized wait-list control design to explore the feasibility and efficacy of a novel detoxification method for GWV exposed to toxicants such as pesticides, nerve gases, and pyridostigmine bromide. Our study included 32 GWV (67% male), with a mean age of 51 (range 43-70, SD = 6.97), who participated in a 4- to 5-week treatment that was hypothesized to reduce the reported psychological and neuropsychological symptoms. Psychological measures used included tests given for the evaluation of neurocognitive function, including motor function for a dominant hand with the grooved pegboard test; verbal and visual immediate and delayed memory with the Wechsler Memory Scale III abbreviated subtests; executive function domains of attention, speed, and mental flexibility with trail making test parts A and B and Stroop color and word test. Psychological status was measured using the nine subscales of the Symptom Checklist-90-Revised.

Primary outcomes included between-group differences in self-reported psychological measures and a neuropsychological battery at 7-day and 3-month assessments. Baseline comparison revealed improvements in 16 of 19 psychological and neuropsychological measures at 7-day assessment and that 13 remained stable at 3-month assessment.

We conclude that the detoxification procedure provided improvement in psychological and cognitive function for GWV and that future study is warranted.

We conclude that the detoxification procedure provided improvement in psychological and cognitive function for GWV and that future study is warranted.